Patent ID: 11942149
Assignee: MACROGENICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  G | IPC G

Claim 1:
2. The method of claim 1, wherein:
(A) the first Light Chain Variable Domain comprises the amino acid sequence of CD137 MAB-3 VL15 (SEQ ID NO:222), and the first Heavy Chain Variable Domain comprises the amino acid sequence of hCD137 MAB-3 VH1B (SEQ ID NO:84); or
(B) the first Light Chain Variable Domain comprises the amino acid sequence of CD137 MAB-3 VL14 (SEQ ID NO:221), and the first Heavy Chain Variable Domain comprises the amino acid sequence of hCD137 MAB-3 VH1B (SEQ ID NO:84); or
(C) the first Light Chain Variable Domain comprises the amino acid sequence of CD137 MAB-3 11 (SEQ ID NO:218), and the first Heavy Chain Variable Domain comprises the amino acid sequence of hCD137 MAB-3 VH1B (SEQ ID NO:84); or
(D) the first Light Chain Variable Domain comprises the amino acid sequence of CD137 MAB-3 VL10 (SEQ ID NO:217), and the first Heavy Chain Variable Domain comprises the amino acid sequence of hCD137 MAB-3 VH1B (SEQ ID NO:84); or
(E) the first Light Chain Variable Domain comprises the amino acid sequence of CD137 MAB-3 VL6 (SEQ ID NO:213), and the first Heavy Chain Variable Domain comprises the amino acid sequence of hCD137 MAB-3 VH1B (SEQ ID NO:84); or
(F) the first Light Chain Variable Domain comprises the amino acid sequence of CD137 MAB-3 VL4 (SEQ ID NO:211), and the first Heavy Chain Variable Domain comprises the amino acid sequence of hCD137 MAB-3 VH1B (SEQ ID NO:84).